Business Wire

emnify and Skylo to Unveil the First Converged Cellular and Satellite Connectivity at Mobile World Congress

21.9.2023 10:00:00 EEST | Business Wire | Press release

Share

Today, emnify the leader in cloud-native IoT connectivity solutions, and Skylo, a global software-defined non-terrestrial network (NTN) operator focusing on connecting everything, everywhere, announce an industry-first convergence of satellite and cellular IoT connectivity from a single emnify SIM. Partnering with leading module manufacturer, Murata, the companies are expanding the next generation of IoT connectivity to space. The combination of emnify’s cloud-native, mobile core technology and direct IoT cellular access with providers around the globe, with Skylo’s NTN satellite access, provides seamless, intelligent, friction-free, network IoT connectivity.

The emnify IoT SuperNetwork, the industry’s first cloud-native IoT connectivity service with direct access to over 540 cellular networks in over 180 countries, provides access to Skylo’s satellite NTN services, marking the first and only single SIM access to global IoT connectivity on terrestrial and non-terrestrial networks. This innovation drastically reduces the operational cost and complexity of adding satellite connectivity, delivering on the promise of converged IoT connectivity to meet the needs of scaling IoT businesses, regardless of geographical challenges or local network infrastructure limitations.

"Our collaboration with Skylo underscores our commitment to expanding the SuperNetwork to create new opportunities and open new markets for IoT businesses everywhere," said Frank Stoecker, CEO and emnify founder. "The addition of satellite connectivity exemplifies the power of the SuperNetwork to go beyond traditional networks to provide dedicated IoT connectivity with truly global reach.”

Skylo, the leader in satellite connectivity, shares in the excitement. “We are thrilled to partner with emnify to offer friction-free access to NTN, ensuring that businesses are always connected for critical needs,” said Parthsarathi Trivedi, CEO and Skylo co-founder. "This innovation in IoT connectivity provides new levels of reliability and device availability, expanding IoT’s reach to previously inaccessible areas, and bringing new use cases to life."

“It’s critical that IoT customers have reliable, cost-effective, integrated hardware solutions to take advantage of innovations in IoT connectivity,” said Mehul Udani, Vice President Corporate Technology and Innovation for Murata. “Murata’s combined cellular and NTN radio modules provide a breakthrough in offering converged connectivity around the globe.”

Transformative use cases highlight converged IoT connectivity potential

Remote Monitoring Systems

In remote regions lacking traditional infrastructure, the unparalleled reach of the SuperNetwork with Skylo’s NTN satellite connectivity will enable reliable monitoring of water resources. The SuperNetwork ensures that sensors always use the appropriate network in their location.

According to Matt Trumbo, Director of Product Management for In-Situ, “For our markets, NTN effectively means you can use your cellular devices anywhere – no worrying about coverage, no hassles with local providers and network compatibility. It’s the benefits of traditional satellite data providers at an order of magnitude less in cost and in power consumption. NTN will completely alter how we partner with our customers to create decision-quality information.”

Asset Tracking

The SuperNetwork’s advanced reach and reliability with Skylo’s NTN satellite connectivity is necessary to enable breakthrough use cases and opportunities in asset tracking. High value assets are often stationed permanently or temporarily in remote, previously unconnected areas. Powered by a single emnify SIM, IoT tracking devices and sensors provide continuous data to monitor equipment location, movement and critical telemetry needed for services such as predictive maintenance, usage optimization, and security.

“We're excited about the possibility of merging satellite and cellular connectivity for GPS tracking in remote and rural areas. It's a compelling solution that extends our tracking capabilities to places where conventional cell networks can't reach. This innovation not only broadens our service coverage but also ensures connectivity in the most remote locations, enhancing the reliability of our GPS tracking solutions,” said Adam Ben Jacob Director of Sales, Support & Technology for OneStep GPS. “Our team is eager to dive into testing and deployment.”

New SuperNetwork Eval Program

emnify and Skylo are offering a new evaluation program for customers interested in deploying converged cellular and satellite connectivity. This program will allow selected participants to work directly with emnify and Skylo to test their use cases and the capabilities of the SuperNetwork to jumpstart their converged IoT connectivity transformation with hands-on support and guidance from a team of IoT experts.

Deploying IoT Satellite Roundtable at Mobile World Congress, Las Vegas

emnify is hosting an invite-only roundtable discussion on September 26, from 2:30-5:30. The roundtable, moderated by Matt Hatton, founding partner at Transforma Insights, features speakers from Skylo and Murata to discuss this next level of connectivity and how IoT businesses can take advantage of increased availability, lower power consumption, and a limitless footprint.

To register your interest in attending the roundtable please visit https://www.mwclasvegas.com/agenda/session/deploying-iot-satellite-in-2024-discover-new-technologies-to-expand-your-iot-connectivity.

To learn more about converged cellular and satellite IoT connectivity and the SuperNetwork, stop by the emnify booth, #839, at Mobile World Congress.

For more information and updates on the event please visit https://www.emnify.com/events/mwc-las-vegas-2023.

About emnify

emnify is the leading cloud building block for cellular communications in the IoT stack, connecting millions of IoT devices globally – from electric vehicles to energy meters, alarm systems to GPS trackers, thermometers to health wearables. The emnify API and SIM technology connect and secure any kind of IoT deployment to its application back-end. emnify’s cloud-native integrations and no-code workflows ensure seamless lifecycle scalability for deployments of all sizes – from start-up to enterprise. The award-winning emnify IoT SuperNetwork is the largest globally distributed mobile cloud core network of its kind, supporting local network access (2G – 5G, LTE-M, NB-IoT and satellite) in over 180 countries from more than 25 cloud regions – and counting. emnify’s solution is built on partnerships with the leading hyperscale cloud service providers, system integrators, and hundreds of network operators worldwide.

About Skylo

Skylo Technologies is an NTN service provider based in Mountain View, CA, offering a service that allows smartphone and IoT cellular devices to connect directly over existing satellites. Devices connected over satellite are managed and served by Skylo’s commercial NTN vRAN, featuring a 3GPP standards-based cloud-native base station and core. Skylo works with existing satellite operators, terrestrial mobile network operators, and device makers to provide subscribers an anywhere, anytime connectivity solution that seamlessly roams between terrestrial and satellite networks. Skylo’s focus is on enabling connected services for people outdoors and connected workflows for machines at work across critical industries such as agriculture, maritime, logistics, mining, and others, in addition to mass-market consumer devices. For more information, visit www.skylo.tech, contact info@skylo.tech, or follow us on LinkedIn and Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

emnify Media Relations Contact:
Jennifer Baisch
emnify
media@emnify.com

Skylo Media Relations Contact:
Rosa Lear
Skylo Technologies
press@skylo.tech

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye